NAM
UTHR icon

Nissay Asset Management’s United Therapeutics UTHR Stock Holding History

Nissay Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93M Buy
5,416
+76
+1% +$42.8K 0.01% 465
2026
Q1 		$3.17M Sell
5,340
-155
-3% -$77.2K 0.02% 408
2025
Q4 		$2.68M Buy
5,495
+15
+0.3% +$6.99K 0.01% 441
2025
Q3 		$2.3M Buy
5,480
+37
+0.7% +$12.4K 0.01% 470
2025
Q2 		$1.56M Buy
5,443
+208
+4% +$62.2K 0.01% 555
2025
Q1 		$1.61M Buy
5,235
+43
+0.8% +$14.7K 0.01% 557
2024
Q4 		$1.87M Buy
5,192
+61
+1% +$22.4K 0.01% 539
2024
Q3 		$1.84M Sell
5,131
-149
-3% -$50.3K 0.01% 549
2024
Q2 		$1.68M Sell
5,280
-122
-2% -$32.3K 0.01% 540
2024
Q1 		$1.24M Buy
5,402
+90
+2% +$20.3K 0.01% 606
2023
Q4 		$1.17M Buy
5,312
+218
+4% +$50.2K 0.01% 591
2023
Q3 		$1.15M Buy
5,094
+219
+4% +$50.4K 0.01% 581
2023
Q2 		$1.08M Buy
4,875
+213
+5% +$47.2K 0.01% 593
2023
Q1 		$1.04M Buy
+4,662
New +$1.15M 0.01% 598
2019
Q2 		– Sell
-5,029
Closed -$590K – 752
2019
Q1 		$590K Buy
5,029
+144
+3% +$16.8K 0.02% 613
2018
Q4 		$532K Sell
4,885
-70
-1% -$8.12K 0.02% 593
2018
Q3 		$634K Buy
4,955
+130
+3% +$16.1K 0.02% 595
2018
Q2 		$546K Buy
4,825
+128
+3% +$14.1K 0.02% 620
2018
Q1 		$528K Buy
4,697
+131
+3% +$16.6K 0.02% 615
2017
Q4 		$676K Buy
+4,566
New +$580K 0.02% 565

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Nissay Asset Management's UTHR Position: Q2 2026 in Review

Nissay Asset Management increased its United Therapeutics (UTHR) stake by 1.4% in Q2 2026, buying an estimated $42.8K and bringing the position to 5,416 shares worth $2.93M. The position accounts for 0.01% of the portfolio, ranked #465.

Nissay Asset Management first reported a position in UTHR in Q4 2017 and has held it in 20 quarters since. The position peaked at $3.17M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Nissay Asset Management held 5,416 shares of United Therapeutics worth $2.93M as of Q2 2026.
  • Nissay Asset Management bought 76 United Therapeutics shares in Q2 2026, an estimated $42.8K.
  • United Therapeutics made up 0.01% of Nissay Asset Management's portfolio in Q2 2026, its #465 holding.
  • Nissay Asset Management first reported a position in United Therapeutics in Q4 2017 and has held it in 20 quarters since.
  • Nissay Asset Management's United Therapeutics position peaked at $3.17M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Nissay Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.